Session III: September 18, 2024

Progress Toward Making Prostate Cancer a Chronic Disease

Prostate cancer is increasingly being recognized as a chronic condition, like diabetes or heart disease, due to advancements in early detection, effective management strategies, and a deeper understanding of the disease’s progression. Many people now live with prostate cancer for over 15-20 years. Effective management is crucial, especially for advanced prostate cancer. While the disease may not be entirely eradicated, it can be controlled through combination or continuous treatments.

This session provides essential information for prostate cancer survivors and their caregivers, emphasizing the importance of managing the disease as a chronic condition.

Session III Program

Watch Video Moderator: Keith Crawford, MD, PhD, PHEN Director of Clinical Trials and Patient Education

Watch Video Welcome and Opening Remarks: Mr. Thomas Farrington, President and Founder, PHEN

Watch Video Celebrating 20 Years of Summit – Part 3: Ms. Tomeeka Miller, PHEN Director of Communications

Watch Video Urologist’s Perspective on Progress Toward Making Prostate Cancer a Chronic Disease: Mark Pomerantz, MD, Medical Oncologist, Dana-Farber Cancer Institute

Watch Video Industry Perspective on Progress in Making Prostate Cancer a Chronic Disease

Pfizer: Geeta Devgan, PhD, Prostate Cancer Team Lead US Medical Affairs
Sofie Company: Robert Bridwell, MD, Medical Advisor
Bayer: Jay Jhaveri, MD, MPH, Medical Director, US Medical Affairs – Oncology Managing Prostate Cancer
Essa Pharma: Alessandra Cesano, MD, PhD, Chief Medical Officer, Executive Vice President
Johnson & Johnson: Peter Francis, MD, MBA, Global Medical Affairs Lead, Early Prostate Cancer